about
sameAs
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transitionGlobal epidemiology and genotype distribution of the hepatitis C virus infectionDisability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Modeling the Health and Economic Burden of Hepatitis C Virus in SwitzerlandHepatitis C virus infection.Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis.Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data.Economic burden of hepatitis C-associated diseases in the United States.Hepatitis C virus infection in Argentina: Burden of chronic disease.Chronic hepatitis C virus (HCV) disease burden and cost in the United States.Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift.Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease BurdenEconomic burden of hepatitis C in Egypt: the future impact of highly effective therapies.Trends and projections of hepatitis C virus epidemiology in Latin America.A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas.Historical epidemiology of hepatitis C virus (HCV) in selected countries.Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.The current and future disease burden of chronic hepatitis C virus infection in Egypt.Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective study.Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment.Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece.Global genotype distribution of hepatitis C viral infection among people who inject drugs.The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3.Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.Forecasting the disease burden of chronic hepatitis C virus in Poland.The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.Historical Trends in the Hepatitis C Virus Epidemics in North America and AustraliaChronic hepatitis C virus (HCV) burden in Rhode Island: modelling treatment scale-up and elimination.Making the case for looking beyond WHO estimates for the global burden of hepatitis C and B.Strategies to manage hepatitis C virus infection disease burden - volume 3.Estimating HCV disease burden - volume 3 (editorial).Disease burden of chronic hepatitis C in Brazil.
P50
Q21034169-05D0FB3A-B912-4D37-BBC3-8D655C81B9B5Q24170269-8B1B773A-9C5A-41A6-B88E-0F76940C65D8Q27001240-1E89EF2D-6E9D-4806-B781-5BB6EDEF309DQ27860791-F6B1794A-33FA-4DDD-A141-6526F10A0707Q27860879-B6FE8C47-D31E-485F-9576-EA22A75246E6Q28548657-EDD54B0E-388C-4764-A8DA-0D881199946EQ30235491-CB4FC90A-7944-43A4-B244-12DEE50B0500Q30251862-CB99D521-8CF4-43A4-8D78-6FFE05CEEEFDQ30358426-CDC0C75A-710C-4E1D-A6A2-9CC786C1F79FQ30403548-2DBFE186-DE02-49CB-A4C6-2683E44E49DDQ33926017-6E54371C-8184-459A-9474-68BD5B49948DQ34253963-CA2825FA-48F7-4BE2-BD35-056B53CB1805Q36924982-082976F3-25F1-4969-9C81-6F71EDD15429Q37148328-AD27871E-A52E-485A-B200-717A37E6353EQ37189531-D5113790-1548-47CC-8000-2FF016539C82Q37246465-6DC6102D-68B6-42DF-993F-37DF12CFFE25Q37279353-3070842A-26BF-4331-9B74-DAEA348DDF6AQ37886279-7FAB2903-8573-429C-8513-BB97F5A68E0DQ37886280-A7DCED48-8A5F-4210-95A6-BD46F2F6F8D5Q37998148-D6D3FF8D-E17E-439E-B043-0DAEEFD91696Q38203033-5D72B8ED-AFFA-4057-A8C5-35C0CD3EDE54Q38233245-A39DEA21-2685-43BA-A7F0-C81747649183Q38237346-10ADF52C-899C-457D-A112-86763CE46E6EQ38627907-FF1D2E44-D5C4-4700-A23E-7C4B857377A4Q38670084-6566E8BD-0A28-4621-AB0A-6F39C975080EQ38838703-9F79437E-C4DD-4824-B255-A2C845169A2BQ38842781-E57C629B-ED21-4880-8834-AD7154FBC96BQ38926642-C08A71EB-A0AE-46AA-ABC8-4C63E16FFF1BQ38948615-5A5669AF-2BBB-4441-9126-83EA4748264EQ38948620-45F7C0E5-C822-4AC4-83D1-EF3BC0E741D3Q39064153-FF408E77-F4E9-4813-8909-0E81D2C1FBB6Q39075044-E1C6C1EF-0C92-453E-871A-BF0250A689FBQ39093905-63178C0B-2F1D-467C-B9FA-DBC5501A72C8Q39213684-80591C1A-98BB-4EA6-B0B6-940EBD6F7C9AQ39403806-79CCA037-8AD0-4188-9491-4810CB4A5031Q40588090-138918B7-126B-407F-9CC7-B7F0323FA0AFQ40722371-443BBA42-7F55-4839-B26E-A30B4288C159Q40932583-0EF180C6-D220-4CFF-8D04-EC8AFEC7D3CBQ40932598-D484B814-4106-4370-B08B-C9C3728CE8FFQ41178496-D95F3FFD-6453-422C-AA83-DA42DB978380
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Homie Razavi
@ast
Homie Razavi
@en
Homie Razavi
@es
Homie Razavi
@nl
Homie Razavi
@sl
type
label
Homie Razavi
@ast
Homie Razavi
@en
Homie Razavi
@es
Homie Razavi
@nl
Homie Razavi
@sl
altLabel
Homaune Razavi
@en
Razavi H
@en
prefLabel
Homie Razavi
@ast
Homie Razavi
@en
Homie Razavi
@es
Homie Razavi
@nl
Homie Razavi
@sl
P106
P1153
39862058000
P21
P31
P496
0000-0002-2658-6930